Clinical Value of 89Zr-trastuzumab PET

Clinical trial NCT01832051 · COMPLETED

Trial details

NCT number: NCT01832051
Sponsor: University Medical Center Groningen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2013-03-01
Primary completion: 2015-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.